These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 9744860)

  • 1. DNA damage activates p53 through a phosphorylation-acetylation cascade.
    Sakaguchi K; Herrera JE; Saito S; Miki T; Bustin M; Vassilev A; Anderson CW; Appella E
    Genes Dev; 1998 Sep; 12(18):2831-41. PubMed ID: 9744860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.
    Liu L; Scolnick DM; Trievel RC; Zhang HB; Marmorstein R; Halazonetis TD; Berger SL
    Mol Cell Biol; 1999 Feb; 19(2):1202-9. PubMed ID: 9891054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.
    Barlev NA; Liu L; Chehab NH; Mansfield K; Harris KG; Halazonetis TD; Berger SL
    Mol Cell; 2001 Dec; 8(6):1243-54. PubMed ID: 11779500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
    Gu W; Roeder RG
    Cell; 1997 Aug; 90(4):595-606. PubMed ID: 9288740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment.
    Wang H; Zhao Y; Li L; McNutt MA; Wu L; Lu S; Yu Y; Zhou W; Feng J; Chai G; Yang Y; Zhu WG
    J Biol Chem; 2008 Feb; 283(5):2564-74. PubMed ID: 17977830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305.
    Wang YH; Tsay YG; Tan BC; Lo WY; Lee SC
    J Biol Chem; 2003 Jul; 278(28):25568-76. PubMed ID: 12724314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.
    Sasaki T; Gan EC; Wakeham A; Kornbluth S; Mak TW; Okada H
    Genes Dev; 2007 Apr; 21(7):848-61. PubMed ID: 17403783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
    Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
    Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.
    Jin Y; Zeng SX; Dai MS; Yang XJ; Lu H
    J Biol Chem; 2002 Aug; 277(34):30838-43. PubMed ID: 12068014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF.
    Liu Y; Colosimo AL; Yang XJ; Liao D
    Mol Cell Biol; 2000 Aug; 20(15):5540-53. PubMed ID: 10891493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.
    Kobet E; Zeng X; Zhu Y; Keller D; Lu H
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12547-52. PubMed ID: 11070080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.
    Deng L; Wang D; de la Fuente C; Wang L; Li H; Lee CG; Donnelly R; Wade JD; Lambert P; Kashanchi F
    Virology; 2001 Oct; 289(2):312-26. PubMed ID: 11689053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone acetyltransferase promotes fluoride toxicity in LS8 cells.
    Deng H; Fujiwara N; Cui H; Whitford GM; Bartlett JD; Suzuki M
    Chemosphere; 2020 May; 247():125825. PubMed ID: 31927229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Max is acetylated by p300 at several nuclear localization residues.
    Faiola F; Wu YT; Pan S; Zhang K; Farina A; Martinez E
    Biochem J; 2007 May; 403(3):397-407. PubMed ID: 17217336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.
    Espinosa JM; Emerson BM
    Mol Cell; 2001 Jul; 8(1):57-69. PubMed ID: 11511360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
    Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
    J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of E2F1 activity by acetylation.
    Martínez-Balbás MA; Bauer UM; Nielsen SJ; Brehm A; Kouzarides T
    EMBO J; 2000 Feb; 19(4):662-71. PubMed ID: 10675335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
    Thomas MC; Chiang CM
    Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.
    Momii Y; Izumi H; Shiota M; Onitsuka T; Abe T; Kobayashi H; Miyamoto N; Uchiumi T; Kohno K
    Oncol Rep; 2007 Aug; 18(2):411-6. PubMed ID: 17611664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.